NEW YORK (GenomeWeb News) – Sigma-Aldrich said Tuesday that it will distribute Stemgent’s lentiviral vector-based technologies to the stem cell research community through a global agreement.

The worldwide distribution agreement covers Stemgent’s lentivirus-based delivery systems for induced pluripotent stem cells.

It includes Stemgent’s viral vectors, Sigma-Aldrich’s lentivirus technology, and Dox Inducible expression from Heidelberg, Germany-based TET Systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.